Should pulmonary metastases from colorectal cancer be resected? Tom Treasure MD MS FRCS FRCP Clinical Operational Research Unit UCL (Department of Mathematics)

Slides:

Advertisements

Similar presentations

Is there a role for surgery in metastatic colorectal cancer?

Advertisements

Follow-up of GI Cancers Dr. Marianne Taylor BC Cancer Agency – CSI November 29, 2003.

Long term follow-up after pulmonary radiofrequency ablation T. de Baère, Institut Gustave Roussy - Villejuif - France.

Goldstraw et al. J Thorac Oncol 2007 Why should we want to screen? Survival (years)

High Intensity Focused Ultrasound (HIFU) for Liver Tumour Dr Dai Wing Chiu Queen Mary Hospital.

Management of colorectal cancer with liver metastasis Dr. Vivian Lee Department of Surgery, UCH.

Malignant Pleural Mesothelioma Post- Irradiation Treatment for Hodgkin’s Lymphoma Thea Price MD, R.V. Sooppan MD, Michael Walker MD Department of Thoracic.

Matthew Kilmurry, M.D. St. Mary’s General Hospital Grand River Hospital.

Journal Meeting 時間 : AM 07:30 日期 : 06/29/2007 地點 : 胸腔外科辦公室報告人 : R2 許博順.

Radiofrequency Ablation of Lung Cancer

Neoadjuvant Imatinib, Surgery and then ? Seattle 2007 Neoadjuvant Imatinib, Surgery and then ? Department of Surgery 1 and Medical Oncology 2 Netherlands.

Management of Colorectal Liver Metastasis

Pulmonary Metastasis From Osteosarcoma Multi-factorial analysis of survival at first lung involvement Ali Aljubran, Martin Blackstein for the University.

Lars Påhlman Dept. Surgery, Colorectal unit, University Hospital, Uppsala, Sweden How to handle peritoneal carcinomatosis found at laparotomy.

SURGEONS ROLE AND INVOLVEMENT IN SBRT PROGRAM Stephen R. Hazelrigg, M.D. Professor and Chair, Cardiothoracic Surgery Southern Illinois University, School.

© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Colorectal Cancer Early detection of disease Precise Staging.

NECN Lung NSSG April 2012 Managing Solitary Brain Metastases from NSCLC Dr Paula Mulvenna Consultant Clinical Oncologist Northern Centre for Cancer Care.

Experience and Outcomes with Hypofractionated Concurrent Chemoradiation for Stage III NSCLC at NCCC Gregory Webb Medical Student.

Resection For Lung Metastases M62 Coloproctology Course.

The effect of surgeon volume on procedure selection in non-small cell lung cancer surgeries Dr. Christian Finley MD MPH FRCSC McMaster University.

The Safety, Efficacy, and Durability of Lung Volume Reduction Surgery: A 10-Year Experience Mark E. Ginsburg, MD, Byron M. Thomashow, MD, William M. Bulman,

An Assessment of Factors Affecting Outcome in Patients Presenting with Metastatic Soft Tissue Sarcoma Peter Ferguson MD1,2, Benjamin Deheshi MD1,2, Anthony.

SYNCHRONOUS COLORECTAL AND LIVER RESECTION J Peter A Lodge MD FRCS HPB and Transplant Unit St James’s University Hospital Leeds LS9 7TF 2006 Association.

Acknowledgements This report differs from the submitted abstract due to further subdivision of patients into analytic and non- analytic, and focus on the.

Management of the primary in Stage IV colorectal cancer Erin Kennedy, MD, PhD, FRCSC Colorectal Surgery Mount Sinai Hospital University of Toronto.

Evidence Based Approach 5-Year Survival Rate for Breast Cancer Stage IV is 14% 2 to 5 percent become long-term survivors, possibly cured of their disease.

LUCADA Jacqueline Brown Cancer Services Manager North Tees & Hartlepool Trust.

Rachel Rowlands 17 th May  2012 Be Clear on Cancer campaign  Aims of the study  Methodology  Results  Conclusions  Limitations  Recommendations.

Mamoun A. Rahman Surgical SHO Mr Osborne’s team. Introduction Blood transfusion: -Preoperative ( elective) -Intra/postoperative ( urgent) Blood transfusion.

Radical surgery is the preferable treatment option for T1- 2/N0 low rectal cancer Jose G. Guillem, MD, MPH Department of Surgery Memorial Sloan Kettering.

National Cancer Intelligence Network Outcome and the effect of age in 1318 patients with synovial sarcoma: Report from the National Cancer Intelligence.

Surgery of colorectal metastasis in the Optimox 1 study. A GERCOR Study. N. Perez-Staub, G. Lledo, F. Paye, B. Gayet, M. Flesch, A. Cervantes, A. Figer,

Pt ZJ 19yo M that presented to Seattle Children’s for evaluation of 3 lesions found on recent PET CT ◦ One large mass in the posterior mediastinum just.

Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer Anna Bill-Axelson, M.D., Lars Holmberg, M.D., Ph.D., Mirja Ruutu, M.D., Ph.D., Michael.

Complete pathologic responses in the primary of rectal or colon cancer treated with FOLFOX without radiation A. Cercek, M. R. Weiser, K. A. Goodman, D.

How clinicians use data to make an impact on clinical outcomes Dr Mick Peake Clinical Lead, National Cancer Intelligence Network Consultant & Senior Lecturer.

Variation in place of death from cancer: studies in South East England Elizabeth Davies, Peter Madden, Victoria Coupland, Karen Linklater, Henrik Møller.

Emily Tanzler, MD Waseet Vance, MD

Brain imaging prior to lung cancer resection

Surgical treatment of hepatic and pulmonary metastases from colon cancer James R Headrick, MD, Daniel L Miller, MD, David M Nagorney, MD, Mark S Allen,

Prognosis of younger patients in non-small cell lung cancer

Lung Cancer Screening:

Cancer in Wales Population incidence of stage at diagnosis Official statistics Published 09:30 hrs 24 November

Figure 1 Underreporting of treatment-related toxicities by physicians, relative to patients with either advanced-stage lung cancer, or early-stage breast.

Prediction of Prognosis and Surgical Indications for Pulmonary Metastasectomy From Colorectal Cancer Toshihiko Iizasa, MD, Makoto Suzuki, MD, Shigetoshi.

Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: Experiences in 167 patients Joachim Pfannschmidt,

Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma Giulio Melloni, MD, Claudio.

Surgical treatment of hepatic and pulmonary metastases from colon cancer James R Headrick, MD, Daniel L Miller, MD, David M Nagorney, MD, Mark S Allen,

Long-Term Outcomes After Surgical Resection of Pulmonary Metastases From Colorectal Cancer Hisashi Suzuki, MD, PhD, Moriyuki Kiyoshima, MD, Miyuki Kitahara,

Surgical treatment of non-small cell lung cancer 1 cm or less in diameter Daniel L Miller, MD, Charles M Rowland, MS, Claude Deschamps, MD, Mark S Allen,

Photodynamic Therapy for Early Stage Central Type of Lung Cancer

Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival Pamela Samson, MD, MPHS, Traves.

Prognostic factors in clinical stage I non–small cell lung cancer

Clinical Characteristics and Outcomes for Patients With Thymic Carcinoma: Evaluation of Masaoka Staging Anya M. Litvak, MD, Kaitlin Woo, MS, Sara Hayes,

Does Repeated Lung Resection Provide Long-Term Survival for Recurrent Pulmonary Metastases of Colorectal Cancer? Results of a Retrospective Japanese Multicenter.

Pulmonary Resection for Metastases from Colorectal Cancer

Bolstering the Case for Lobectomy in Stages I, II, and IIIA Small-Cell Lung Cancer Using the National Cancer Data Base Susan E. Combs, MA, Jacquelyn.

Resection of adrenal metastases from non-small cell lung cancer: a multicenter study Henri Porte, MD, PhD, Joëlle Siat, MD, Benoit Guibert, MD, Francoise.

Is there a role for pneumonectomy in pulmonary metastases?1

Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma Masayoshi Inoue, MD, Mitsunori Ohta, MD, Keiji Iuchi, MD, Akihide.

James D Luketich, Michael E Burt The Annals of Thoracic Surgery

NAACCR/IACR Combined Annual Conference 2019

Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer Pamela Samson, MD, Aalok Patel,

Neal S Goldstein, MD The Annals of Thoracic Surgery

Prognosis of angiosarcoma at different anatomic sites

The Development of an International Registry

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma Joachim Pfannschmidt, MD, Hans Hoffmann, MD, PhD, Thomas.

Outcome after Pulmonary Metastasectomy: Analysis of 5 Years Consecutive Surgical Resections 2002–2006 Kåre Hornbech, MD, Jesper Ravn, MD, Daniel Andreas.

Surgery for pulmonary metastases from colorectal carcinoma

Presentation transcript:

Should pulmonary metastases from colorectal cancer be resected? Tom Treasure MD MS FRCS FRCP Clinical Operational Research Unit UCL (Department of Mathematics) London

My starting point: If I get colorectal cancer I would be grateful for your skill to control the primary cancer I’d hope for a cure BUT If you fail to cure me... I will want to know the evidence base for any further treatment offered

Antony Gormley’s “Field ” Reported series with 40% 5 year survival not a random sample are from an unknown denominator with great variation amongst individuals

A solitary nodule – what is it? Colorectal metastasis Primary lung cancer Something else 1.Clinical context 2.Smoking history 3.Radiological review (Lindell Radiology 2007) 4.Tissue diagnosis 5.If intraoperative diagnosis work up with NSCLC in mind

Evaluation Patient – Age – Sex – Symptoms – FEV1 Cancer – Date of primary CRC resection (interval) – Stage of primary at CRC resection – Present control/status (including PET) – Number of metastases – Carcinoma embryonic antigen (CEA)

When not to offer metastactomy? Short interval – how short? Multiple metastases – how many? Raised CEA – mixed messages! Annals Thoracic Surgery 2009;87:1685 N= to 2007 Duke MSK-CC

When not to offer metastactomy? Short interval – NOT < 12 months Multiple metastases – NOT > 3 Raised CEA – the CEA paradox Annals Thoracic Surgery 2009;87:1685 N= to 2007 Duke MSK-CC

JAMA 1994;272:31 JTO 2010;5:S179

Where is the evidence? 51 surgical follow up studies 3504 patients 1960s to 2000s

Survival averages 40%... in selected patients Evidence based on * 60% solitary metastasis 36 months interval * JRSM 2010;103:60 ** JTO 2008;3:1257 Practice 146 ESTS members ** Multiple no obstacle 85% <12 months alright 93% Synchronous alright 73%

Increasing interval between the primary resection and the metastasectomy Many Mets One Met J Thorac Oncol 2010; 5(6 Suppl 2):S200-S202 A thought experiment...

Modelling outcomes on Thames Cancer Registry data Countr y YearPatients5 YS Reported (95% confidence intervals) 5 YS by Model USA Japan Arch Surg 1992; 127:1403 J Thorac Cardiovasc Surg 1996; 112:867 “Better out than in” Utley et al. Proceedings of the 33rd International Conference on Operational Research Applied to Health Services

Survival Time following resection of primary Modelling with Thames Cancer Registry data

Dukes A Dukes B Dukes C unknown Dukes D Thanks to South Thames Cancer Registry, UK 5 yr survival 75% - 10% Months Proportion of patients still alive

J Thorac Cardiovasc Surg Oct;112(4):867-74

Proportion of patients still alive

Modelling outcomes on Thames Cancer Registry data Countr y YearPatients5 YS Reported (95% confidence intervals) 5 YS by Model USA % Japan % Arch Surg 1992; 127:1403 J Thorac Cardiovasc Surg 1996; 112:867 “Better out than in” Utley et al. Proceedings of the 33rd International Conference on Operational Research Applied to Health Services

Modelling outcomes on Thames Cancer Registry data Countr y YearPatients5 YS Reported (95% confidence intervals) 5 YS by Model USA % (32%-48%)55% Japan % (33%-48%)50% Arch Surg 1992; 127:1403 J Thorac Cardiovasc Surg 1996; 112:867 “Better out than in” Utley et al. Proceedings of the 33rd International Conference on Operational Research Applied to Health Services

Two closing thoughts Belief is more powerful than evidence But trials can bring a surprise

33 Blalock 1944 Ranks 13 th of 293 unique cited papers Cited by 14/51 index papers (High five 31,30,27,22,22)

34 New England J Medicine 1944; 231:

35 Annals of Thoracic Surgery 1980;30:378

36

N = 100, 385, 121, MD Anderson 2008 New York collected 2009 Boston 2007 MSK-CC

And finally: thank you for you interest! If I get colorectal cancer I would be grateful for your skill to control the primary cancer I’d hope for a cure BUT If you fail, please do NOT use up the rest of my days in unavailing therapies.